← Leaderboards
Jacob Joseph
University Of Arkansas Med Scis Ltl Rock
$469,286
Attributed
$469,286
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249.8K · FY2008–25$250K$187.5K$125K$62.5K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$469,286 · 2
VA$0 · 2
By mechanism
R21$412,840 · 1
M01$56,446 · 1
I01$0 · 2
Top collaborators
- Jack Rubinstein5 shared
- Wen-Chih Wu5 shared
Others in their field
Top investigators on “Heart Failure”
- Judith S Hochman · New York University School Of Medicine$120,321,606
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$51,947,333
- Lisa P Jacobson · Johns Hopkins University$45,397,923
- Walter N Kernan · Yale University$42,197,025
- Dalane W Kitzman · Wake Forest University$40,701,149
- David Couper · Univ Of North Carolina Chapel Hill$37,959,091
Research focus
Heart FailurePreservationSiteInnovationDatabasesEfracEventVeteransHospitalizationMortalityHealthcare SystemsBaseUnited States Department Of Veterans AffairsAnimalsMouse ModelLaboratoriesIn VivoLinkPhenotypeFutureFunctional DisorderPositioning AttributeDesignCessation Of Life
Grant awards (15)
Treatment of Veterans with Heart Failure with Reduced Ejection Fraction with Probenecid$0
I01 · FY2025 · VA
Treatment of Veterans with Heart Failure with Reduced Ejection Fraction with Probenecid$0
I01 · FY2024 · VA
Pragmatic Approaches to Capture and Ascertainment of Clinical Trial Endpoints$0
I01 · FY2023 · VA · contact PI
Treatment of Veterans with Heart Failure with Reduced Ejection Fraction with Probenecid$0
I01 · FY2023 · VA
Pragmatic Approaches to Capture and Ascertainment of Clinical Trial Endpoints$0
I01 · FY2022 · VA · contact PI
Pragmatic Approaches to Capture and Ascertainment of Clinical Trial Endpoints$0
I01 · FY2022 · VA · contact PI
Treatment of Veterans with Heart Failure with Reduced Ejection Fraction with Probenecid$0
I01 · FY2022 · VA
Pragmatic Approaches to Capture and Ascertainment of Clinical Trial Endpoints$0
I01 · FY2021 · VA · contact PI
Treatment of Veterans with Heart Failure with Reduced Ejection Fraction with Probenecid$0
I01 · FY2021 · VA
Pragmatic Approaches to Capture and Ascertainment of Clinical Trial Endpoints$0
I01 · FY2020 · VA · contact PI
Pragmatic Approaches to Capture and Ascertainment of Clinical Trial Endpoints$0
I01 · FY2019 · VA · contact PI
Selenium, Glutathione Peroxidase-1, and Homocysteine-induced Cardiac Remodeling$113,526
R21 · FY2009 · HL · contact PI
Selenium, Glutathione Peroxidase-1, and Homocysteine-induced Cardiac Remodeling$49,518
R21 · FY2009 · HL · contact PI
Selenium, Glutathione Peroxidase-1, and Homocysteine-induced Cardiac Remodeling$249,796
R21 · FY2008 · HL · contact PI
G-CSF for Mobilization of Bone Marrow Stem Cells$56,446
M01 · FY2004 · RR